Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2022

Nov 15, 2022

30870_dirs_2022-11-15_765e1af2-23d5-4d12-a43f-51f81e0915ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-11-14

Reporting Person: Wong Robert (VP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-14 Common Stock S 2100 $40.68 Disposed 30537 Direct